Doctors Without Borders Seeks To Undo Gilead Hep C Patent
Doctors Without Borders and five organizations have appealed the European Patent Office's decision upholding Gilead Sciences Inc.'s patent for the hepatitis C drug sofosbuvir, the international nonprofit announced on Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article